LDHA and non-small cell lung carcinoma: Once in the TME, lactate serves as an energy source for the proliferation of tumor‐associated immune cells.[8, 14] Intriguingly, we observed that LDHA was more closely associated with immunotherapy resistance than MCT4 in NSCLC, implying that intracellular lactate also affects immune cells within TME.